Rastrum bioprinter

Inventia Expands Bioprinting Facility in Australia With Government Support

Australian bioprinting startup Inventia Life Science is expanding its local footprint with support from the New South Wales (NSW) government. The Alexandria-based biotech company, a global leader in 3D cell…

Inventia Life Science Opens its First U.S. Bioprinting Office in Delaware

Bioprinting machine manufacturer Inventia Life Science has opened its first U.S. office and facility at Delaware NGO The Innovation Space. The Sydney, Australia-based startup will benefit from the rich life…

Inventia Snags $3.2M in New Funding to Commercialize Bioprinter

After announcing a Series B round last January, Sydney-headquartered biotech startup Inventia received an additional AU$4.4 million ($3.2 million) from Australian pension fund giant HESTA. This latest investment brings Inventia’s…

Sydney Bioprinting Firm Closes $25M Series B Round

In a Series B round led by Australia’s largest venture capital (VC) firm, Blackbird Ventures, Sydney-headquartered biotech startup Inventia raised $25 million (A$35 million). The company also landed in the…

Featured

What It Takes to Design a Bioprinter for Cancer Research, from Inventia Life Sciences

At a time when experts predict cancer will remain a massive health problem, advances in technology can make a big difference. Earlier this year, the World Health Organization (WHO) announced…

Inventia Life Science Empowers Researchers to Rapidly Scale 3D Cell Culture

No disease has ever been as overwhelming as cancer. Not only does it kill close to 10 million people every year, but even though we still fail to understand how…

Award for Inventia Life Science’s Bioprinter That Creates Tumors for Cancer Research

In 2018, Sydney-based startup Inventia Life Science and researchers at the University of New South Wales (UNSW) built Rastrum, a new bioprinter which uses inkjet technology to print human cells…